No One Should Be Surprised By This

Breitbart is reporting today on some of the things the Democrats plan to do now that they have taken over the House of Representatives.

The article reports:

Rep. Brad Sherman (D-CA) plans to introduce articles of impeachment against President Donald Trump on Thursday — the first day that Democrats control the majority in the U.S. House of Representatives.

…Newly-elected Rep. Rashida Tlaib (D-MI) also endorsed impeaching Trump on her first day in office, according to The Nation, which described Tlaib as calling for “immediate steps” to remove the president from the White House.

“Each passing day brings more pain for the people most directly hurt by this president, and these are days we simply cannot get back. The time for impeachment proceedings is now,” Rep. Tlaib declared.

Representative Sherman wants to impeach President Trump for obstructing justice by firing former FBI Director James B. Comey, among other wrongdoing.

The article states:

“There is no reason it shouldn’t be before the Congress,” Sherman said. “Every day, Donald Trump shows that leaving the White House would be good for our country.”

I don’t know what these people are looking at, but the middle class has come roaring back since President Trump took office. The unemployment numbers are down, there are more jobs than people looking for work, people have more spending money in their pockets, manufacturing is coming back to America, better trade deals have been negotiated, America’s carbon dioxide emissions are down, and North and South Korea are talking to each other. Which one of these accomplishments do you think the American people are willing to impeach President Trump for?

The Economic Recovery Is Still Struggling

Market Watch is reporting today that New York area manufacturing conditions fell rapidly in August.

The article reports:

The Empire State general business conditions index nose-dived to a reading of negative 14.9, from positive 3.9 in July, marking the worst level since April 2009, the New York Fed said. The index, on a scale where any positive number indicates improving conditions, was far worse than the positive 4.5 forecast in a MarketWatch-compiled economist poll.

The article includes the following chart:

NewYorkStateManufacturingConditions

The only good news in this is that the decline may cause the Federal Reserve to delay interest increases for a while.

Another Industry Suffering From Overregulation

The Washington Examiner posted an article today on the government-caused drug shortages America is experiencing. Yes, you read that right.

The article reports that prescription drug shortages tripled from 2005 to 2010 and reached record levels in 2011 as manufacturers ceased operations or ran into production problems.

The article reports:

Last year, nearly half of hospitals reported experiencing a drug shortage on a daily basis, according to a survey of 820 hospitals by the American Hospital Association. About 82 percent of hospitals said they delayed treatment because of a shortage, and 35 percent of hospitals said patients experienced “adverse outcomes.” The survey did not categorize those outcomes, a spokeswoman said.

So what is going on? The Federal Food and Drug Administration (FDA) has increased its enforcement efforts. The article explains:

…the FDA’s “zero tolerance” regime is forcing manufacturers to abide by rules that are rigid, inflexible and unforgiving. For example, a drug manufacturer must get approval for how much of a drug it plans to produce, as well as the timeframe. If a shortage develops (because, say, the FDA shuts down a competitor’s plant), a drug manufacturer cannot increase its output of that drug without another round of approvals. Nor can it alter its timetable production (producing a shortage drug earlier than planned) without FDA approval.

We elected this government. We are responsible. The only way to fix this is to unelect everyone who has worked toward bigger government and more regulation and elect people who want smaller government and less regulation. It’s up to us.

 

Enhanced by Zemanta